Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbon nanoparticles suspension injection in colorectal cancer surgery
ChiCTR-OPR-17012049Phase 4Recruiting
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Mar 2017
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Kanarine in colorectal cancer (CRC) (2 arms), sponsored by Fudan University Shanghai Cancer Center. Primary endpoints: Count of lymph nodes and Count of positive lymph nodes. Started Mar 2017; status: recruiting.
02
Drugs
Kanarine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR-OPR-17012049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPR-17012049.